Although insulin is the more potent hypoglicemic agent, the availability of a wider spectrum of therapeutic agents, many of which are better tolerated than insulin, has reduced the field of application for insulin treatment; presently, insulin is used only in those who cannot maintain an adequate glycemic control with other drugs. Furthermore, a lively research activity is currently ongoing, in order to make insulin therapy even safer and simpler for patients.

Role of insulin in the type 2 diabetes therapy: past, present and future / Rotella CM; Pala L; Mannucci E. - In: INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM. - ISSN 1726-9148. - ELETTRONICO. - (2013), pp. 137-144.

Role of insulin in the type 2 diabetes therapy: past, present and future.

ROTELLA, CARLO MARIA;PALA, LAURA;MANNUCCI, EDOARDO
2013

Abstract

Although insulin is the more potent hypoglicemic agent, the availability of a wider spectrum of therapeutic agents, many of which are better tolerated than insulin, has reduced the field of application for insulin treatment; presently, insulin is used only in those who cannot maintain an adequate glycemic control with other drugs. Furthermore, a lively research activity is currently ongoing, in order to make insulin therapy even safer and simpler for patients.
2013
137
144
Rotella CM; Pala L; Mannucci E
File in questo prodotto:
File Dimensione Formato  
intj endocrinoland metabolismRotella3.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 141.8 kB
Formato Adobe PDF
141.8 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/959606
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 23
  • ???jsp.display-item.citation.isi??? ND
social impact